Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-173,300
Closed -$16.1M – 6746
2025
Q4
$16.1M Buy
173,300
+105,800
+157% +$11.5M ﹤0.01% 2588
2025
Q3
$8.41M Buy
+67,500
New +$8.58M ﹤0.01% 3138
2017
Q1
– Sell
-1,500
Closed -$94K – 6884
2016
Q4
$94K Hold
1,500
– – ﹤0.01% 6169
2016
Q3
$84K Buy
+1,500
New +$71.9K ﹤0.01% 6309
2016
Q1
– Sell
-100
Closed -$4K – 7194
2015
Q4
$4K Sell
100
-1,100
-92% -$38.8K ﹤0.01% 7059
2015
Q3
$38K Buy
1,200
+1,100
+1,100% +$34.3K ﹤0.01% 6877
2015
Q2
$3K Sell
100
-2,100
-95% -$76.3K ﹤0.01% 7215
2015
Q1
$80K Sell
2,200
-7,200
-77% -$268K ﹤0.01% 6521
2014
Q4
$398K Buy
9,400
+5,100
+119% +$204K ﹤0.01% 5495
2014
Q3
$169K Buy
4,300
+4,000
+1,333% +$160K ﹤0.01% 6291
2014
Q2
$12K Sell
300
-600
-67% -$22.8K ﹤0.01% 6918
2014
Q1
$32K Buy
900
+800
+800% +$30.3K ﹤0.01% 6640
2013
Q4
$4K Buy
+100
New +$4.24K ﹤0.01% 6608

Other funds holding ITRI

Goldman Sachs's ITRI Position: Q2 2026 in Review

Goldman Sachs reduced its Itron (ITRI) stake by 20% in Q2 2026, selling an estimated $8.26M and leaving 390,028 shares worth $33.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2146.

Goldman Sachs first reported a position in ITRI in Q2 2013 and has held it in 53 quarters since. The position peaked at $129M in Q2 2025. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Goldman Sachs held 390,028 shares of Itron worth $33.7M as of Q2 2026.
  • Goldman Sachs sold 96,727 Itron shares in Q2 2026, an estimated $8.26M.
  • Itron made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2146 holding.
  • Goldman Sachs first reported a position in Itron in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Itron position peaked at $129M in Q2 2025.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.